Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy.
Am J Pathol. 2010 Nov;177(5):2622-34. doi: 10.2353/ajpath.2010.091075. Epub 2010 Oct 1.
Loss of the PTEN tumor suppressor gene occurs frequently in non-small-cell lung carcinoma (NSCLC), although neither genetic alterations nor epigenetic silencing are significant predictors of PTEN protein levels. Since recent reports implicated neural precursor cell expressed, developmentally down-regulated 4-1 (NEDD4-1) as the E3 ubiquitin ligase that regulates PTEN stability, we investigated the role of NEDD4-1 in the regulation of PTEN expression in cases of NSCLC. Our findings indicate that NEDD4-1 plays a critical role in the development of NSCLC and provides novel insight on the mechanisms that contribute to inactivate PTEN in lung cancer. Immunohistochemical analysis on tissue microarrays containing 103 NSCLC resections revealed NEDD4-1 overexpression in 80% of tumors, which correlated with the loss of PTEN protein (n=98; P<0.001). Accordingly, adoptive NEDD4-1 expression in NSCLC cells decreased PTEN protein stability, whereas knock-down of NEDD4-1 expression decreased PTEN ubiquitylation and increased PTEN protein levels. In 25% of cases, NEDD4-1 overexpression was due to gene amplification at 15q21. In addition, manipulation of NEDD4-1 expression in different lung cell systems demonstrated that suppression of NEDD4-1 expression significantly reduced proliferation of NSCLC cells in vitro and tumor growth in vivo, whereas NEDD4-1 overexpression facilitated anchorage-dependent and independent growth in vitro of nontransformed lung epithelial cells that lack pRB and TP53 (BEAS-2B). NEDD4-1 overexpression also augmented the tumorigenicity of lung cancer cells that have an intact PTEN gene (NCI-H460 cells).
抑癌基因 PTEN 的缺失在非小细胞肺癌(NSCLC)中频繁发生,尽管遗传改变和表观遗传沉默都不是 PTEN 蛋白水平的显著预测因子。由于最近的报告表明神经前体细胞表达的发育下调蛋白 4-1(NEDD4-1)是调节 PTEN 稳定性的 E3 泛素连接酶,我们研究了 NEDD4-1 在 NSCLC 中调节 PTEN 表达中的作用。我们的研究结果表明,NEDD4-1 在 NSCLC 的发生发展中起关键作用,并为导致肺癌中 PTEN 失活的机制提供了新的见解。含有 103 例 NSCLC 切除标本的组织微阵列的免疫组织化学分析显示,80%的肿瘤中存在 NEDD4-1 过表达,这与 PTEN 蛋白缺失相关(n=98;P<0.001)。因此,在 NSCLC 细胞中过表达 NEDD4-1 会降低 PTEN 蛋白稳定性,而敲低 NEDD4-1 表达则会降低 PTEN 泛素化并增加 PTEN 蛋白水平。在 25%的病例中,NEDD4-1 过表达是由于 15q21 基因扩增所致。此外,在不同的肺细胞系统中操纵 NEDD4-1 表达表明,抑制 NEDD4-1 表达可显著减少 NSCLC 细胞在体外的增殖和体内肿瘤的生长,而 NEDD4-1 过表达可促进缺乏 pRB 和 TP53 的非转化肺上皮细胞(BEAS-2B)在体外的锚定依赖性和非依赖性生长。NEDD4-1 过表达还增强了具有完整 PTEN 基因的肺癌细胞(NCI-H460 细胞)的致瘤性。